Skip to main content
Call for Abstracts

Welcome to the ACR Convergence 2023 Abstract Submission Site!

ACR Convergence 2023 is the world’s premier rheumatology meeting. The 2023 in-person meeting in San Diego, CA, will offer scientific sessions, networking opportunities, and more. Those unable to make the in-person event can still attend virtual on-demand sessions, select live-streaming events, and the LIVE Poster Hall. Join us in November for stellar rheumatology education, outstanding networking opportunities, and more.

The American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP) invite you to submit an abstract and take advantage of the opportunity to have your work peer reviewed by experts in the field. If accepted, your abstract will be published in an online supplement of the Arthritis & Rheumatology journal and displayed in the distinguished international venue of ACR Convergence 2023.


Please read the complete 2023 Call for Abstracts Guidelines prior to submitting.


New for 2023!

  • CME credit returns for plenary abstract sessions! Employees or owners of ineligible companies may be the presenting author of an abstract in the concurrent oral and poster abstract programs, but to be eligible for plenary consideration, no listed authors of an abstract may be owners/employees of an ineligible company.
  • The in-person Poster Hall comes to San Diego. In 2023, posters will be presented in-person and added to a virtual poster gallery. All poster presenters must attend the meeting in-person. Recordings of poster presentations will no longer be offered on the meeting app or online platform.
  • Poster tours will take place in the in-person Poster Hall.

Read the full instructions for Entering Institution Information to ensure your author block appears correctly

ACR Call for Abstracts

The ACR Convergence program includes content related to the clinical practice and teaching of rheumatology. Abstracts covering basic and translational science that contributes to the understanding of musculoskeletal and rheumatic disease pathogenesis, therapeutic mechanisms and efficacy, and studies investigating healthcare delivery to patients are eligible for submission.

The fee for submitting each abstract is $70. The ACR accepts electronic payment only in the form of MasterCard, Visa, or American Express. Abstract processing fees must be in U.S. funds. All fees are non-refundable—no exceptions. There are no refunds for rejected or withdrawn abstracts.

SUBMISSION DEADLINE: Thursday, June 8, 2023, noon Eastern Time—no exceptions. No changes may be made to your submission, including author information, after the deadline.

ARP Call for Abstracts

The ARP program reflects the needs and interests of healthcare professionals with an interest in rheumatology-related issues by offering a forum to address significant issues with a multidisciplinary audience. Abstracts will be peer reviewed by a subsection of the ARP Annual Meeting Program Subcommittee according to subject categories. ARP abstract sessions will not necessarily be scheduled by individual category.

A $40 processing fee accompanies each ARP abstract submission. The ARP accepts electronic payment only in the form of MasterCard, Visa, or American Express. Abstract processing fees must be in U.S. funds and are non-refundable—no exceptions. There are no refunds for rejected or withdrawn abstracts.

SUBMISSION DEADLINE: Thursday, June 8, 2023, noon Eastern Time—no exceptions. No changes may be made to your submission, including author information, after the deadline.

Abstract Eligibility

Persons Eligible to Submit

  • Members and non-members of the ACR and ARP are eligible to submit an abstract.

    • Abstracts Eligible for Submission

    • Abstracts that have been previously accepted and/or presented at other medical meetings are eligible for submission. These abstracts will go through the same peer review process as any other abstracts.
    • Abstracts describing original basic and clinical science related to the broad area of rheumatic diseases may be submitted.
    • Abstracts reporting results of a clinical trial will be required to identify the trial phase.
    • Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association.

    Abstracts Not Eligible for Submission

    • Abstracts should not report results that have been previously presented at an ACR/ARP Annual Meeting
    • Abstracts that report work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the ACR/ARP submission deadline of noon ET on Thursday, June 8, 2023 are ineligible for consideration.
    • Multiple abstracts may not be submitted for one study unless substantially different research questions are being addressed in each abstract.
    • Abstracts submitted for the ARP program may not be concurrently submitted to the ACR program.
    • Case reports are not considered appropriate and will not be reviewed. We encourage those with interesting cases or images to consider submission to the Thieves Market or Image Competition. See separate submission processes.

    Thank you for your participation in ACR Convergence 2023. The ACR uses a single sign-on process that allows Volunteers and Faculty to log into their portal via their rheumatology.org account.


    Update: ACR is excited to share that we have just launched a new ACR website to enhance the member experience. For this reason, your login page will look different than in the past. If you have any questions or issues, please contact facultymanagement@rheumatology.org.


    Browser Requirements: Google Chrome is the recommended browser for accessing your speaker/moderator resource center. You may experience issues when using Firefox or Microsoft Edge.

    Log in to the Abstract Site

    Questions? Organizer: Lee Boughton -